GLP1R and type 2 diabetes mellitus: In addition, studies indicate that GLP-1 analogs, including liraglutide, reduce the risk of cardiovascular events in T2DM due to the expression of GLP-1 receptor) on different cell types, including endothelial cells and immune cells (Helmstädter et al., 2020).